human plasma-derived phosphate binding protein (CNRS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman plasma-derived phosphate binding protein (CNRS)
Drug Alias NameCEBPbeta/Tat interaction modulators (CNRS)HIV replication inhibitors (CNRS)human phosphate binding proteinHPBP
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products modulatorsCCAAT/enhancer-binding protein beta modulators
TargetsCCAAT/enhancer-binding protein betaHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A